Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;31(5):602-606.
doi: 10.1038/s41431-023-01284-1. Epub 2023 Feb 16.

Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing

Affiliations

Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing

Katherine Dixon et al. Eur J Hum Genet. 2023 May.

Abstract

Germline structural variants (SVs) are challenging to resolve by conventional genetic testing assays. Long-read sequencing has improved the global characterization of SVs, but its sensitivity at cancer susceptibility loci has not been reported. Nanopore long-read genome sequencing was performed for nineteen individuals with pathogenic copy number alterations in BRCA1, BRCA2, CHEK2 and PALB2 identified by prior clinical testing. Fourteen variants, which spanned single exons to whole genes and included a tandem duplication, were accurately represented. Defining the precise breakpoints of SVs in BRCA1 and CHEK2 revealed unforeseen allelic heterogeneity and informed the mechanisms underlying the formation of recurrent deletions. Integrating read-based and statistical phasing further helped define extended haplotypes associated with founder alleles. Long-read sequencing is a sensitive method for characterizing private, recurrent and founder SVs underlying breast cancer susceptibility. Our findings demonstrate the potential for nanopore sequencing as a powerful genetic testing assay in the hereditary cancer setting.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Recurrent deletions of BRCA1 exons 1–2 are mediated by sequence homology between BRCA1 intron 2 and adjacent loci.
Read alignments and contigs derived by local assembly of variant supporting reads at the BRCA1 locus. Telomeric breakpoints within intron 1 of the BRCA1 pseudogene were associated with deletions of 37,470 bp (P1) and 36,056 bp (P2), and breakpoints within NBR2 intron 1 were associated with a deletion of 6649 bp (P3). For clarity, mismatch bases and indels <50 bp are not shown.
Fig. 2
Fig. 2. LRS reveals molecular heterogeneity of CHEK2 exons 9–10 deletions.
Read alignments and contigs derived by local assembly of variant supporting reads at the CHEK2 locus. Reads are colored in blue and pink by haplotype inferred from integrated read-based and reference-guided phasing. Reads that could not be assigned to a haplotype are colored in gray. Local haploid assemblies were generated from reads supporting each variant to refine the breakpoints of the CHEK2 del5395 European founder variant (P11) and the CHEK2 del6188 variant (P14) in representative carriers. SINEs short interspersed nuclear elements. For clarity, mismatch bases and indels <50 bp are not shown.

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky JS, et al. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat. 2017;161:575–86. doi: 10.1007/s10549-016-4085-4. - DOI - PMC - PubMed
    1. Chamseddine RS, Wang J, Yin K, Singh P, Zhou J, Braun D, et al. Abstract PS8-40: Penetrance of male breast cancer susceptibility genes: a systematic review. Cancer Res. 2021;81:PS8–40. doi: 10.1158/1538-7445.SABCS20-PS8-40. - DOI - PubMed
    1. LaDuca H, Stuenkel AJ, Dolinsky JS, Keiles S, Tandy S, Pesaran T, et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med. 2014;16:830–7. doi: 10.1038/gim.2014.40. - DOI - PMC - PubMed
    1. Lincoln SE, Hambuch T, Zook JM, Bristow SL, Hatchell K, Truty R, et al. One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation. Genet Med. 2021;23:1673–80. doi: 10.1038/s41436-021-01187-w. - DOI - PMC - PubMed

Publication types

Grants and funding